Centene (Centene) GF Value : $92.35 (As of Apr. 26, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Centene GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-26), Centene's share price is $74.00. Centene's GF Value is $92.35. Therefore, Centene's Price-to-GF-Value for today is 0.80.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Centene is Modestly Undervalued.

Centene (NYSE:CNC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Centene's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	74.00	/	92.35
	=	0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centene GF Value Related Terms

Thank you for viewing the detailed overview of Centene's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Centene (Centene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

CNC:Mexico 1CNC:Italy QEN:Germany QEN:Germany C1NC34:Brazil

Address

7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105

Website

https://www.centene.com

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Executives

Lori Jean Robinson	director	5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher	officer: EVP, CFO	8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray	officer: EVP, Chief Transform. Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford	director	C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola	officer: EVP, Health Care Enterprises	500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley	officer: EVP, Chief Admin. Officer	7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt	director	822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin	director
H James Dallas	director	127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks	officer: SVP, Chief Information Officer	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas	officer: EVP, MARKETS	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A	officer: EVP, Mergers & Acquisitions	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105